Advocacy Actions

2019-09-17 > Beijing

Comments to the SAMR's Interim Measures for Handling Complaints and Reporting in Market Supervision and Administration (Draft for Comments)

On 17th September, the Chamber submitted comments to the State Administration for Market Regulation on the Interim Measures for Handling Complaints and Reporting in Market Supervision and Administration (Draft for Comments).

Read more
2019-09-12 > Beijing

Comments to the National Medical Products Administration on the Regulations on Random Inspection of Medical Devices Quality

On 27 August 2019, the Department of Comprehensive Affairs from National Medical Products Administration (NMPA) has initiated public consultations on Regulations on Random Inspection of Medical Devices Quality.

Read more
2019-09-12 > Beijing

Comments to the NMPA's Public Consultation on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments)

On 12th September, the medical device sector submitted comments to the National Medical Products Administration on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments).

Read more
2019-09-02 > Beijing

update the procurement issue from medical equipment sector to the EU Delegation

update the procurement issue from medical equipment sector to the EU Delegation

Read more
2019-08-26 > Beijing

meeting with China Society for Drug Regulation (CSDR)

Meeting with China Society for Drug Regulation - Jessica Yuan will join the Legislative Research Group on future Law of P.R.China on the Administration of Medical Devices

Read more
2019-08-23 > Beijing

Meeting with the International Cooperation Department on Proposals for NMPA's Visit to Russia

Meeting with the International Cooperation Department on Proposals for NMPA's Visit to Russia, like to meet with the Association for Medical Devices

Read more
2019-08-22 > Beijing

Provide a presentation on "Buy China" Issue in medical device sector to be discussed with DG TRADE

Public Procurement in China: preference to domestic brands! COCIR Office in Europe will communicate and ask for support from DG GROW and DG TRADE

Read more
2019-08-20 > Beijing

Advocacy Letter to the Enforcement and Anti-Monopoly Division of the Guangxi Administration for Market Regulation

On 20th August, the medical devices sector submitted an advocacy letter to the Enforcement and Anti-Monopoly Division of the Guangxi Administration for Market Regulation.

Read more
2019-08-19 > Beijing

Lobby Letter to Supervisory Office, General Office of State Council on "Domestic Brand" Procurement Issue

Public Procurement in China: Preference to Domestic Brands! Actions being taken by COCIR/HCE WG

Read more
2019-08-14 > Beijing

Advocacy Letter to the National Medical Products Administration on Government Information Disclosure

On 14th August, the Medical Device Sector submitted an advocacy letter to the National Medical Products Administration on government information disclosure.

Read more